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Abstract Using the yeast two-hybrid assay and in vivo binding
assay, we investigated whether B-myb oncogene products (B-
myb) can associate with each other. Specificity tests of the yeast
two-hybrid system showed a self-association of B-myb proteins in
yeast. Cotransfection experiments demonstrated that B-myb
proteins form a complex in vivo. Deletion analysis revealed that
this binding was sufficiently mediated by the carboxy-terminal
conserved region of B-myb. In addition, the B-myb self-
association is directly dependent on the amount of expressed B-
myb in cells and slightly increased by the dephosphorylation
state. These results suggested that B-myb could form a complex
and influence its transcriptional activity.
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1. Introduction
B-myb is a member of the myb family of transcription fac-
tors including A-myb and c-myb [1]. A number of lines of
evidence indicate that B-myb is important in controlling cell
proliferation and di¡erentiation [2^5]. In contrast to the re-
stricted expression of c-myc, the most characterized member
of the family, B-myb expression is more ubiquitous and is cell
cycle-dependent [1,6]. Expression of B-myb is down-regulated
in resting cells but is signi¢cantly induced during G1/S tran-
sition and the S phase of the cell cycle. B-myb expression is
decreased during terminal di¡erentiation of promyelocytic
and neuroblastoma cell lines [4,7,8], and the proliferation of
human leukemic cells is inhibited by introduction of antisense
B-myb oligonucleotides [7]. Consistent with these observa-
tions, overexpression of B-myb was found to overcome G1
blocks mediated by checkpoint regulators such as p53 and
p107 [5,9]. In addition, recent studies suggested that B-myb
function is associated with the presence of cofactors such as
cyclin A and cyclin E and is dependent on its phosphorylation
[10,11]. These data strongly indicate that B-myb, like c-myb,
plays a fundamental role in cellular proliferation.
B-myb has three functional domains for transactivation
[12]: a DNA binding domain, an acidic region for transcrip-
tional activation, and a carboxy-terminal conserved region
which is a proline-rich domain and shows signi¢cant homol-
ogy with other members of the myb gene family such as A-
myb and c-myb. The mechanism of B-myb transcriptional ac-
tivity has not been elucidated, but a recent study apparently
indicated that the conserved region is critical for transactiva-
tion by B-myb, presumably via the binding of some cofactors
that may be involved in the modi¢cation and activation of B-
myb [13]. The conserved region was suggested to be a protein
binding domain and a putative phosphorylation site. Using an
a⁄nity resin, analysis of the metabolically labeled CV-1,
HeLa and/or NIH3T3 cells showed that several cellular pro-
teins were bound to the conserved region in a cell type-speci¢c
manner [13]. In addition, recent studies showed that the cyclin
A-cdk2 complex could induce phosphorylation of B-myb and
potentiate the transcriptional activity of B-myb [10,11,14]. In
view of the multiplicity of protein-protein interactions in
many transcription factors containing basic helix-loop-helix
(b-HLH) and leucine zipper (LZ) motifs, the possibility of
investigating the dimerization and/or oligomerization of B-
myb in vivo is attractive since the biological importance of
and structural similarities in the carboxy-terminus of the myb
family suggest that the conserved region containing many pro-
line residues and a putative ankyrin repeat-like motif may
function for protein-protein interactions.
In this study, we report a self-association of B-myb in vivo.
Deletion studies demonstrate that the carboxy-terminal con-
served region is critical for B-myb self-association. Moreover,
the B-myb self-association is regulated by both the degree of
expression and the phosphorylation state, at least in part, of
B-myb. These results suggest that the self-association is crit-
ical for modulation of the transactivation by B-myb.
2. Materials and methods
2.1. Cell lines and reagents
293T cells, a derivative of human kidney embryonal ¢broblast con-
taining SV40 T antigen, were obtained from Dr. E.S. Jun (Korea
Research Institute of Science and Technology, Taejon, South Korea)
and cultured in Dulbecco’s modi¢ed Eagle’s medium (DMEM) sup-
plemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin-
streptomycin and 1 mM glutamine in an atmosphere of 5% CO2 at
37‡C. The anti-FLAG (M2) antibody, dithiothreitol (DTT), aprotinin,
and phenylmethylsulfonyl £uoride (PMSF) were purchased from Sig-
ma (St. Louis, MO, USA). The mouse hybridoma cell line producing
anti-GST antibody was generously provided by Dr. D.S. Im (Korea
Research Institute of Science and Technology, Taejon, South Korea).
Polyvinylidene di£uoride (PVDF) membrane was purchased from
Millipore Corp. (Bedford, MA, USA). Oligonucleotides were synthe-
sized from Bioneer Corp. (Cheongwon, Chungbuk, South Korea).
2.2. Cloning of a full-length human B-myb cDNA
A partial B-myb cDNA (pJG4-5-B-myb) obtained from a HeLa cell
cDNA library was kindly provided by Dr. Y. Yang (Korea Research
Institute of Science and Technology, Taejon, South Korea). A human
keratinocyte cDNA library [15] was screened using pJG4-5-B-myb as
a probe. Positive clones, contained within the pBluescript SK3 phag-
emid, were excised in vivo from the Uni-ZAP XR vector using Ex-
Assist helper phage system (Stratagene, La Jolla, CA, USA), follow-
ing the protocol recommended by the manufacturer. The largest clone
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(V2.8 kb) containing the full-length cDNA for human B-myb (acces-
sion number X13293) was chosen and sequenced on both strands.
2.3. Expression constructs
A partial B-myb cDNA (pJG4-5-B-myb) was subcloned as an
EcoRI/XhoI fragment into the EcoRI/SalI site of pFLAG-CMV-2.
The eukaryotic glutathione S-transferase (GST) expression vector
(pEBG) was kindly supplied by Dr. E.S. Jun. pEBG-B-myb, an ami-
no-terminally truncated version containing part of the acidic region
and a complete conserved region, and pEBG-WT-B-myb containing a
full-length B-myb cDNA were constructed in several steps. We ¢rst
cloned the EcoRI/XhoI fragment of B-myb cloned in pJG4-5 into
pBacPAK9 (Clontech, Palo Alto, CA, USA), digested it with EcoRI
plus NotI and subcloned it into pBluescript KS (Stratagene, La Jolla,
CA, USA). Finally, the ClaI/NotI fragment of the resulting plasmid
was cloned into pEBG cut with ClaI and NotI, yielding pEBG-B-myb.
The HindIII/BamHI fragment of pFLAG-WT-B-myb (see below) was
used to generate pEBG-WT-B-myb. To generate two deletion con-
structs, pEBG-B-mybR1 and pEBG-B-mybR2, and a wild-type B-
myb construct, pFLAG-WT-B-myb, we performed a PCR using the
full-length B-myb cDNA as the template. The forward primers for B-
mybR1 (5P-GCGAATTCCTGAACTT CTGGAACAAA-3P), B-
mybR2 (5P-GCGAATTCAAGGAGG TGCTGCGTTCT-3P), and
WT-B-myb (5P-GCAAGCTTATGTCTCGGCGGACGCGC-3P) con-
tain an EcoRI and a HindIII site (underlined). The reverse primers for
B-mybR1 and B-mybR2 (5P-GCCTCGAGCTGGGC CACTGC-
TGCCTT-3P) and WT-B-myb (5P-GCGAATTCCTCCAAGGGCT-
3P) contain a XhoI and an EcoRI site (underlined). The ampli¢ed
PCR products for deletion mutants were cut with EcoRI plus XhoI
and cloned into pEBG as described above. The pFLAG-WT-B-myb
was generated after subcloning of the HindIII/EcoRI PCR fragment
into the HindIII/EcoRI site of pFLAG-CMV-2 containing an EcoRI/
XhoI fragment of B-myb (nucleotides 930^2627). The identity of all
PCR products was con¢rmed by nucleotide sequencing analysis on
both strands with the T7 Sequencing kit (Pharmacia).
2.4. Yeast two-hybrid assay
The 353 amino acids (nucleotides 1010^2068) of the human B-myb
were cloned in frame into the LexA coding sequence to generate a bait
plasmid, pEG202-B-myb. pEG202-B-myb and a ¢sh plasmid, pJG4-5
harboring B-myb, were introduced into a yeast strain containing a
chromosomal copy of the Leu2 gene (EGY48 (MatK trp1 ura3-52
leu2: :pLeu2-lexAop6(vUAS leu2)) and an episomal L-galactosidase
gene under the control of a synthetic promoter with LexA binding
sites [16]. The L-galactosidase activity was used for selection of pro-
teins interacting with the B-myb.
2.5. Cotransfection and in vivo interaction assay
293T cells grown in DMEM supplemented with 10% FBS were
plated in 6-well £at-bottomed microplates (Costar, Cambridge, MA,
USA) at a concentration of 2U105 cells per well the day before trans-
fection. 1 Wg of each plasmid DNA was transfected into 293T cells
with Lipofectin (Life Technologies, Inc.). Forty-eight hours after
transfection, cells were washed three times with ice-cold phosphate-
bu¡ered saline and solubilized with 100 Wl of lysis bu¡er (20 mM
HEPES (pH 7.9), 10 mM EDTA, 0.1 M KCl, and 0.3 M NaCl)
containing 0.1% Nonidet P-40, 10 Wg/ml aprotinin, 10 Wg/ml leupep-
tin, 10 mM sodium £uoride, 2 Wg/ml K-1-antitrypsin, 2 mM sodium
pyrophosphate, 25 mM sodium L-glycerophosphate, 1 mM sodium
orthovanadate, and 1 mM PMSF. Detergent-insoluble materials
were removed by centrifugation at 13 000 rpm for 15 min at 4‡C.
Approximately 80 Wl of the cleared lysates were mixed with 15 Wl of
glutathione-Sepharose beads (Pharmacia, Uppsala, Sweden) and ro-
tated for 2 h at 4‡C. Beads were washed three times with the lysis
bu¡er. The bound proteins were eluted by boiling in SDS sample
bu¡er, subjected to SDS-polyacrylamide gel electrophoresis, and
then transferred to PVDF membranes. The membranes were probed
with an anti-FLAG (M2) antibody and then developed using an en-
hanced chemiluminescence (ECL) detection system (Amersham Phar-
macia Biotech). The relative quantity of the level of B-myb self-asso-
ciation was estimated using a densitometer (Molecular Dynamics) and
ImageQuant software.
Fig. 1. B-myb gene products interact with each other in the yeast
two-hybrid system. Speci¢city test for determining the speci¢city of
interactors was performed on yeast expressing the B42 transactiva-
tion domain fused to B-myb proteins (¢sh) and indicated heterolo-
gous LexA-fused baits. Transformants were assayed for L-galactosi-
dase activity by the colony color assay. The colony color assay
showed either white (3), blue (++), or dark blue (+++) colonies.
References of sources of the analyzed baits are as follows: PTP-
BAS [17]; B-myb [1] ; R-PTP-k [15]; MPK38 [21]; KIAA0175, a hu-
man counterpart of MPK38 [22]; pag [23]; monocyte/neutrophil
elastase inhibitor [24].
Fig. 2. In vivo self-association of B-myb proteins. GST alone
(pEBG), as a control, and pEBG-WT-B-myb were cotransfected
with pFLAG-WT-B-myb into 293T cells by Lipofectin. After 48 h,
cells were extracted in a lysis bu¡er containing 0.1% Nonidet P-40.
GST fusion proteins were puri¢ed on glutathione-Sepharose beads
(GST puri.) and analyzed on a SDS-polyacrylamide gel, and the
complex formation (upper left) and the FLAG-tagged B-myb
(FLAG-Myb) of the amount used for the in vivo binding assay
(upper right) were determined by anti-FLAG antibody immunoblot.
The same blot was stripped and re-probed with an anti-GST anti-
body (lower panel) to con¢rm expression of the GST fusion protein
(GST-Myb) and the GST control (GST).
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3. Results
3.1. B-myb gene products interact with each other in vivo
B-myb was initially isolated in a two-hybrid screen for a
protein interacting with the PDZ domain of PTP-BAS, a pro-
tein tyrosine phosphatase [17,18] (data not shown). To verify
the interaction speci¢city of B-myb, the B-myb library plasmid
was rescued from the galactose-dependent Leu/lacZ yeast
and reintroduced into the original selection PTP-BAS bait
strain as well as the other strains containing di¡erent baits
available in our laboratory, including B-myb bait. From trans-
formants, B-myb cDNA was found to interact with the B-myb
and PTP-BAS but not with the other baits containing unre-
lated sequences (Fig. 1). To determine whether the self-asso-
ciation of B-myb could occur in vivo, we performed cotrans-
fection experiments using GST- and FLAG-tagged eukaryotic
expression vectors. In these experiments, the wild-type B-myb
was coexpressed as a GST fusion protein and a FLAG-tagged
protein in 293T cells. The interactions of FLAG-tagged B-
myb proteins to the GST-B-myb fusion proteins were analyzed
by immunoblotting with an anti-FLAG antibody. As shown
in Fig. 2, the FLAG-tagged B-myb was coprecipitated with
GST-B-myb but not with GST alone used, indicating that
these B-myb proteins physically interact with each other in
Fig. 3. Immunoblot analysis of the deletion mutants of the B-myb. A: Schematic representation of B-myb deletion mutants, B-mybR1 and B-
mybR2. The structure of the wild-type human B-myb is depicted with the relative locations of its DNA binding domain, acidic region, and con-
served region indicated. Amino acid number of domain boundaries is indicated. Arrows represent the three tandem repeats in the DNA binding
domain. B: Mapping of the site on B-myb involved in the self-association. 293T cells were cotransfected with GST alone (pEBG), pEBG-B-
mybR1 (GST-MybR1), or pEBG-B-mybR2 (GST-MybR2), together with pFLAG-B-myb (FLAG-Myb). Transfected cells were extracted and
puri¢ed with glutathione-Sepharose beads, and immunoblotted with an anti-FLAG antibody as in Fig. 2. The puri¢ed GST fusion proteins
(upper left, lower) and the total cell lysates (upper right) were analyzed by immunoblotting with anti-GST (lower panel) and anti-FLAG anti-
bodies (upper panel).
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mammalian cells. Expression of amounts of GST- and FLAG-
tagged B-myb proteins (Fig. 2, lower and upper right, respec-
tively) in cells was also con¢rmed by protein immunoblot
analysis with the antibodies to GST and FLAG.
3.2. Mapping of the region of B-myb for self-association
To determine which regions of B-myb were required for
self-association observed in vivo, we generated two deletion
constructs (Fig. 3A) and transformed them into yeast with B-
myb, together with a B-myb bait harboring part of the acidic
region and a complete conserved region. In the yeast two-
hybrid interaction studies, compared with the pEG202:B-
myb, the pEG202:B-mybR1 including a carboxy-terminal
conserved region displayed a comparable interaction with
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the B-myb, but barely detectable with pEG202:B-mybR2
made by the deletion of a further 89 amino acids (data not
shown). These data indicate that the integrity of the carboxy-
terminal conserved region is important for B-myb self-associ-
ation. Using in vivo binding assays, we subsequently con-
¢rmed that the conserved region is necessary for the self-asso-
ciation of B-myb in vivo. As demonstrated in Fig. 3B, we
failed to detect association of FLAG-tagged B-myb with the
transfected GST-B-mybR2 in 293T cells, but the binding be-
tween the FLAG-tagged B-myb and GST-B-mybR1 became
readily detectable. These results clearly de¢ne the conserved
region as essential for B-myb self-association in vivo and
strongly indicate that the region conserved between c-myb,
A-myb and B-myb may act as a potential binding site for
some cofactors critical for the transactivation by B-myb.
3.3. Modulations of B-myb self-association
It has been shown that B-myb is speci¢cally phosphorylated
by the cyclin A/cdk2 complex during S phase and potentiates
its transcriptional transactivation function [10,14,20]. These
pieces of evidence led us to investigate the requirement of
phosphorylation in the self-association of B-myb. Compared
with the control extracts, which were treated with the tyrosine
and serine/threonine phosphatase inhibitors, cell extracts pre-
pared without phosphatase inhibitors slightly increased com-
plex formation, indicating a minor role for dephosphorylation
in the regulation of B-myb self-association (Fig. 4A,B). More-
over, to distinguish between Ser/Thr and Tyr phosphoryla-
tion, di¡erent phosphatase inhibitors were employed. As
shown in Fig. 4A, we observed that both Ser/Thr and Tyr
phosphorylation are important in the regulation of B-myb
self-association since the Ser/Thr or Tyr phosphatase inhibi-
tors alone were not su⁄cient to in£uence the B-myb self-asso-
ciation. Therefore, it seems reasonable to speculate that the
phosphorylation state of the conserved region, although to a
somewhat lesser extent, may be involved in the self-associa-
tion of B-myb compared to the e¡ect of the conserved region
itself. It has been demonstrated previously that B-myb mRNA
expression is strictly regulated in cycling cells [8,19]. There-
fore, we assessed whether the cell cycle progression can in£u-
ence the B-myb self-association in cells following serum with-
drawal. As illustrated in Fig. 4C,D, after serum starvation, we
observed a slight decrease in the levels of B-myb self-associa-
tion in a time-dependent manner and did not ¢nd a detectable
level of B-myb self-association after 9 h starvation prior to
transfection, whereas self-association was weakly observed
after 5 h starvation. Expression of amounts of the GST-
and FLAG-tagged B-myb precipitated by glutathione-Sephar-
ose beads in 293T cells was con¢rmed by immunoblotting
with either an anti-FLAG antibody (Fig. 4C, upper panel)
or an anti-GST antibody (Fig. 4C, lower panel). After 9 h
starvation, although there was no detectable B-myb self-asso-
ciation, the expression of the GST- and FLAG-tagged B-myb
was easily observed from the coprecipitates with glutathione-
Sepharose beads and the cell lysates, respectively (Fig. 4C,
lower right and upper right). It is evident from this experiment
that, although the kinetics of withdrawal of cells from the cell
cycle by serum starvation do not directly correlate with the
reduction in the amounts of the expressed B-myb proteins, this
association is a biologically relevant low a⁄nity interaction
and dependent on the B-myb protein levels in cells.
4. Discussion
In this study, we demonstrated that B-myb proteins interact
with each other via the carboxy-terminal conserved region in
vivo, and that the self-association of B-myb is apparently
dependent on its expression levels. Furthermore, B-myb self-
association is, at least in part, a¡ected by changes in the
phosphorylation state of B-myb.
Comparison of known sequences of the myb gene family
such as c-myb, A-myb, and B-myb indicates that all three
members of the myb gene family share a signi¢cant degree
of homology conserved in evolution, suggesting that the con-
served region is likely to be an important determinant for
Myb activity in cells. Recently, it was postulated that B-
myb might function as a transcriptional activator or repressor
depending on the type of cells in various tissues. Currently
there is still little information available on the mechanism of
regulating the speci¢city of B-myb transcriptional activity, but
analyses of the carboxy-terminal conserved region of B-myb
provide evidence that the cellular factors bound to the con-
served region are critical for the cell type-speci¢c transcrip-
tional activity of B-myb [13]. These ¢ndings, together with the
presence of many proline residues in the conserved region, led
to the hypothesis that the conserved region may be involved
in protein-protein interactions, and eventually modulates the
DNA binding and transcriptional activation of B-myb. To
test this hypothesis, we prepared a mutant B-myb protein
lacking the conserved region. In vivo binding assays, as dem-
onstrated in Fig. 3B, this protein fails to interact with B-myb.
On the other hand, B-myb:B-myb complexes are generated in
both the wild-type and the mutant protein containing only the
conserved region, indicating that the conserved region may be
a major determinant for association with B-myb proteins
alone.
It has been shown that B-myb is phosphorylated at speci¢c
sites in the conserved region during S phase and that the
Fig. 4. B-myb self-association is regulated by phosphorylation and serum deprivation. A: E¡ect of phosphorylation on the self-association of
B-myb. 293T cells were cotransfected with GST alone (pEBG) or pEBG-WT-B-myb (GST-Myb), together with pFLAG-WT-B-myb (FLAG-
Myb). Cell extracts were prepared in the presence (+PI) and absence (3PI) of phosphatase inhibitors such as sodium pyrophosphate (2 mM),
sodium L-glycerophosphate (25 mM), and sodium orthovanadate (1 mM). The puri¢ed GST fusion proteins (GST puri.) and the total cell ly-
sates (Lysate) were analyzed by immunoblotting with anti-GST (lower panel) and anti-FLAG antibodies (upper panel). To di¡erentiate phos-
phatase inhibitors (right panel), the puri¢ed GST fusion protein extracts were prepared in the presence of the serine/threonine (S/T) or tyrosine
(Y) phosphatase inhibitors. B: Densitometric analysis of B-myb self-association levels (A, upper GST puri.) in the presence and absence of the
phosphatase inhibitors. C: E¡ect of serum deprivation on the self-association of B-myb. 293T cells were transiently cotransfected as described
in A. Cells were incubated in the presence (Serum) and absence (W/O Serum) of serum for the indicated times (5, 9 h) prior to transfection.
D: Densitometric analysis of B-myb self-association levels (C, upper GST puri.) in the presence and absence of serum. In B and D, the level of
B-myb self-association, in arbitrary units, is shown in the graph, after densitometric reading of the autoradiograms and normalization for GST-
Myb (lower GST puri.) and FLAG-Myb (upper Lysate) protein levels.
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modi¢cation of B-myb, by S phase-speci¢c kinases such as
cyclin A/cdk2 complex, may be involved in the B-myb func-
tion [14,20]. Thus, we were interested in examining the possi-
bility that the phosphorylation of B-myb might be associated
with regulation of B-myb self-association. As illustrated in
Fig. 4A,B, the degree of B-myb self-association was slightly
increased in the absence of the phosphatase inhibitors com-
pared to the control. These results indicate a possible role for
Ser/Thr and/or Tyr phosphorylation in the regulation of B-
myb self-association. In our experiments on the serum e¡ect,
as shown in Fig. 4C,D, cotransfection of GST- and FLAG-
tagged B-myb leads to a dose-dependent increase in the com-
plex formation of B-myb due to the increased expression of
exogenous B-myb in the presence of serum. To further inves-
tigate whether the expressed B-myb protein levels could in£u-
ence the self-association, we performed a dose-dependence
experiment by decreasing the expression plasmid (data not
shown). This study clearly demonstrated that B-myb self-as-
sociation is dependent on the amounts of the expressed B-myb
proteins in cells. One possible explanation for this phenomen-
on is that a considerable amount of B-myb proteins is re-
quired for the self-association since the conserved region
thought to mediate this interaction is possibly involved in
interactions with other cellular proteins which compete with
B-myb proteins for binding.
Based on our observed results, we imagine that rather than
directly controlling the transcriptional activity of B-myb, the
self-association likely plays a role that is important in ¢ne-
tuning the regulation of transactivation by B-myb, probably
by competing with the conserved region binding proteins in
cells. We also consider that, in addition to the self-association,
the conserved region of B-myb may apparently participate in
association with other cellular proteins. This would be analo-
gous to the suggested mechanisms by which the cellular co-
factors bound to the conserved region of B-myb are critical
for the cell type-speci¢c transactivation by B-myb [13]. In this
context, the further identi¢cation and characterization of the
interacting proteins associated with the conserved region will
be important to understanding the molecular mechanisms and
functions of the myb gene family.
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